Leukemia Stocks List

Recent Signals

Date Stock Signal Type
2021-03-08 ADPT Volume Surge Other
2021-03-08 ADPT Expansion Breakdown Bearish Swing Setup
2021-03-08 ADPT Reversal New Lows Setup Bearish Swing Setup
2021-03-08 ADPT Slingshot Bearish Bearish Swing Setup
2021-03-08 ADPT Lower Bollinger Band Walk Weakness
2021-03-08 ADPT New Downtrend Bearish
2021-03-08 ANIX 180 Bearish Setup Bearish Swing Setup
2021-03-08 ANIX Fell Below 50 DMA Bearish
2021-03-08 BEAM Stochastic Buy Signal Bullish
2021-03-08 BEAM 180 Bearish Setup Bearish Swing Setup
2021-03-08 BEAM Slingshot Bearish Bearish Swing Setup
2021-03-08 BEAM Lower Bollinger Band Walk Weakness
2021-03-08 CASI 200 DMA Resistance Bearish
2021-03-08 CLLS Slingshot Bearish Bearish Swing Setup
2021-03-08 CRDF 180 Bearish Setup Bearish Swing Setup
2021-03-08 EPZM 180 Bearish Setup Bearish Swing Setup
2021-03-08 EPZM New 52 Week Closing Low Bearish
2021-03-08 ERYP Jack-in-the-Box Bearish Bearish Swing Setup
2021-03-08 INO NR7 Range Contraction
2021-03-08 INO Lower Bollinger Band Walk Weakness
2021-03-08 INO Narrow Range Bar Range Contraction
2021-03-08 INO 180 Bearish Setup Bearish Swing Setup
2021-03-08 NEO Lower Bollinger Band Walk Weakness
2021-03-08 NEO Fell Below 200 DMA Bearish
2021-03-08 PSTX MACD Bearish Centerline Cross Bearish
2021-03-08 SYRS 180 Bearish Setup Bearish Swing Setup
2021-03-08 SYRS Stochastic Buy Signal Bullish
2021-03-08 TEVA 200 DMA Resistance Bearish
2021-03-08 VINC 20 DMA Support Bullish
2021-03-08 VINC 50 DMA Resistance Bearish

Recent News for Leukemia Stocks

Date Stock Title
Mar 8 CASI CASI Pharma and Cleave Therapeutics strike a licensing agreement for CB-5339
Mar 8 ERYP ERYTECH Provides Business Update and Reports Financial Results for the Full Year 2020
Mar 8 TEVA Teva launches first generic version of AZOPT in U.S.
Mar 8 TEVA Teva Announces Launch of First Generic Version of AZOPT® (brinzolamide ophthalmic suspension) 1%, used to treat high pressure inside the eye, in the United States
Mar 8 ADPT FDA Authorizes New Category of Covid-19 Test
Mar 8 CASI CASI Pharmaceuticals To Develop CB-5339 In Cancer Indications In China
Mar 8 ADPT Looking Into Adaptive Biotechnologies's Return On Capital Employed
Mar 8 ANIX Anixa Biosciences to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference
Mar 8 CASI Cleave Therapeutics Licenses First-in-Class VCP/P97 Inhibitor CB-5339 To CASI Pharmaceuticals For Greater China Region
Mar 8 ADPT FDA authorizes Adaptive's T-cell test for people who have already had COVID-19
Mar 8 ADPT Adaptive Biotechnologies Secures FDA EUA For COVID-19 T-Cell Response Test
Mar 8 ERYP Earnings Scheduled For March 8, 2021
Mar 8 ADPT Adaptive Biotech COVID Blood Test Cleared for Emergency Use
Mar 8 ADPT Premarket Movers Monday - GameStop, Athene, Adaptive Biotech
Mar 7 TEVA Teva Pharmaceutical's Ice-Cube Business Model
Mar 7 NEXI Wall Street Breakfast: The Week Ahead
Mar 7 ADPT Adaptive’s T-Detect COVID Test Cleared For Emergency Use In US; Shares Pop 18%
Mar 6 TEVA 10 Best Cheap Stocks To Buy Now According To Billionaire Abrams
Mar 6 ADPT Adaptive Biotechnologies surges 18% afterhours following EUA for COVID-19 test
Mar 6 NEXI Stocks To Watch: Spotlight On DraftKings, 5G Carriers And Roblox

Leukemia, also spelled leukaemia, is a group of cancers that usually begin in the bone marrow and result in high numbers of abnormal white blood cells. These white blood cells are not fully developed and are called blasts or leukemia cells. Symptoms may include bleeding and bruising problems, feeling tired, fever, and an increased risk of infections. These symptoms occur due to a lack of normal blood cells. Diagnosis is typically made by blood tests or bone marrow biopsy.The exact cause of leukemia is unknown. A combination of genetic factors and environmental (non-inherited) factors are believed to play a role. Risk factors include smoking, ionizing radiation, some chemicals (such as benzene), prior chemotherapy, and Down syndrome. People with a family history of leukemia are also at higher risk. There are four main types of leukemia—acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML)—as well as a number of less common types. Leukemias and lymphomas both belong to a broader group of tumors that affect the blood, bone marrow, and lymphoid system, known as tumors of the hematopoietic and lymphoid tissues.Treatment may involve some combination of chemotherapy, radiation therapy, targeted therapy, and bone marrow transplant, in addition to supportive care and palliative care as needed. Certain types of leukemia may be managed with watchful waiting. The success of treatment depends on the type of leukemia and the age of the person. Outcomes have improved in the developed world. The average five-year survival rate is 57% in the United States. In children under 15, the five-year survival rate is greater than 60 to 85%, depending on the type of leukemia. In children with acute leukemia who are cancer-free after five years, the cancer is unlikely to return.In 2015, leukemia was present in 2.3 million people and caused 353,500 deaths. In 2012 it newly developed in 352,000 people. It is the most common type of cancer in children, with three quarters of leukemia cases in children being the acute lymphoblastic type. However, about 90% of all leukemias are diagnosed in adults, with AML and CLL being most common in adults. It occurs more commonly in the developed world.

More about Leukemia
Browse All Tags